Company intelligence / Profile preview
Cellcolabs
Solna, Stockholms Län, Swedencellcolabs.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Conducting trials in the Bahamas through subsidiary Cellcolabs Clinicals to assess MSCs in cardiovascular disease prevention and musculoskeletal injuries. Treatment is carried out through local injection or systemic infusion[4].
- Therapeutic areas
- ImmunologyCardiovascularRheumatology
- Modalities
- Mesenchymal Stem Cells (MSCs)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Collaborations with university hospitals and biotechnology companies[3][4]
Beyond the preview
Go deeper on Cellcolabs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellcolabs.